Functional tissue-engineered blood vessels from bone marrow progenitor cells

Cardiovascular Research

Volumn 75, Issue 3, 2007, Pages 618-628

  Liu, Jin Yu ^a   Swartz, Daniel D ^b   Peng, Hao Fan ^a   Gugino, Sylvia F ^c   Russell, James A ^c   Andreadis, Stelios T ^a  

^a the State University of New York   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Alpha actin promoter; Blood vessels; Bone marrowSmooth muscle cells; Mesenchymal stem cells; Ovine; Ovine animal model; Stem cells; Transcriptional activation; Vascular tissue engineering

Indexed keywords

ALPHA ACTIN; CALDESMON; CALPONIN; COLLAGEN; ELASTIN; MYOSIN HEAVY CHAIN; SMOOTHELIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL; JUGULAR VEIN; LAMB; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING;

ACTINS; ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; BIOMECHANICS; BLOOD VESSELS; CALMODULIN-BINDING PROTEINS; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CYTOSKELETAL PROTEINS; ELASTIN; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; JUGULAR VEINS; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; MYOBLASTS, SMOOTH MUSCLE; MYOSIN HEAVY CHAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHEEP; TISSUE ENGINEERING;

EID: 34447624546     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.04.018     Document Type: Article

References (48)

1. Poh M., Boyer M., Solan A., Dahl S.L., Pedrotty D., Banik S.S., et al. Blood vessels engineered from human cells. Lancet 365 (2005) 2122-2124
2. McKee J.A., Banik S.S., Boyer M.J., Hamad N.M., Lawson J.H., Niklason L.E., et al. Human arteries engineered in vitro. EMBO Rep 4 (2003) 633-638
3. Gaudino M., Cellini C., Pragliola C., Trani C., Burzotta F., Schiavoni G., et al. Arterial versus venous bypass grafts in patients with in-stent restenosis. Circulation 112 (2005) I265-I269
4. Huynh T., Abraham G., Murray J., Brockbank K., Hagen P.O., and Sullivan S. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 17 (1999) 1083-1086
5. Bader A., Steinhoff G., Strobl K., Schilling T., Brandes G., Mertsching H., et al. Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation 70 (2000) 7-14
6. Kaushal S., Amiel G.E., Guleserian K.J., Shapira O.M., Perry T., Sutherland F.W., et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. [comment]. Nat Med 7 (2001) 1035-1040
7. L'Heureux N., Paquet S., Labbe R., Germain L., and Auger F.A. A completely biological tissue-engineered human blood vessel. [comment]. FASEB J 12 (1998) 47-56
8. L'Heureux N., Stoclet J.C., Auger F.A., Lagaud G.J., Germain L., and Andriantsitohaina R. A human tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J 15 (2001) 515-524
9. Niklason L.E., Gao J., Abbott W.M., Hirschi K.K., Houser S., Marini R., et al. Functional arteries grown in vitro. Science 284 (1999) 489-493
10. Niklason L.E., Abbott W., Gao J., Klagges B., Hirschi K.K., Ulubayram K., et al. Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg 33 (2001) 628-638
11. Kim B.S., Nikolovski J., Bonadio J., Smiley E., and Mooney D.J. Engineered smooth muscle tissues: regulating cell phenotype with the scaffold. Exp Cell Res 251 (1999) 318-328
12. Shin'oka T., Imai Y., and Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344 (2001) 532-533
13. Watanabe M., Shin'oka T., Tohyama S., Hibino N., Konuma T., Matsumura G., et al. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng 7 (2001) 429-439
14. Lee S.H., Kim B.S., Kim S.H., Choi S.W., Jeong S.I., Kwon I.K., et al. Elastic biodegradable poly(glycolide-co-caprolactone) scaffold for tissue engineering. J Biomed Mater Res A 66 (2003) 29-37
15. Hoerstrup S.P., Kadner A., Breymann C., Maurus C.F., Guenter C.I., Sodian R., et al. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thorac Surg 74 (2002) 46-52 [discussion]
16. Wake M.C., Gupta P.K., and Mikos A.G. Fabrication of pliable biodegradable polymer foams to engineer soft tissues. Cell Transplant 5 (1996) 465-473
17. Barocas V.H., Girton T.S., and Tranquillo R.T. Engineered alignment in media equivalents: magnetic prealignment and mandrel compaction. J Biomech Eng 120 (1998) 660-666
18. Seliktar D., Nerem R.M., and Galis Z.S. Mechanical Strain-Stimulated Remodeling of Tissue-Engineered Blood Vessel Constructs. Tissue Eng 9 (2003) 657-666
19. Stegemann J.P., and Nerem R.M. Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two- and three-dimensional culture. Exp Cell Res 283 (2003) 146-155
20. Swartz D.D., Russell J.A., and Andreadis S.T. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol 288 (2005) H1451-H1460 [Electronic publication 2004 Oct 14]
21. Galmiche M.C., Koteliansky V.E., Briere J., Herve P., and Charbord P. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 82 (1993) 66-76
22. Shimizu K., Sugiyama S., Aikawa M., Fukumoto Y., Rabkin E., Libby P., et al. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. Nat Med 7 (2001) 738-741
23. Hillebrands J.L., Klatter F.A., van den Hurk B.M., Popa E.R., Nieuwenhuis P., and Rozing J. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 107 (2001) 1411-1422
24. Han C.I., Campbell G.R., and Campbell J.H. Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 38 (2001) 113-119
25. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8 (2002) 403-409
26. Liechty K.W., MacKenzie T.C., Shaaban A.F., Radu A., Moseley A.M., Deans R., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 (2000) 1282-1286
27. Hu B., Wu Z., and Phan S.H. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am J Respir Cell Mol Biol 29 (2003) 397-404
28. Rodriguez L.V., Alfonso Z., Zhang R., Leung J., Wu B., and Ignarro L.J. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci U S A 103 (2006) 12167-12172
29. Niu Y., Xu Y., Zhang J., Bai J., Yang H., and Ma T. Proliferation and differentiation of prostatic stromal cells. BJU Int 87 (2001) 386-393
30. Geer D.J., Swartz D.D., and Andreadis S.T. In vivo model of wound healing based on transplanted tissue-engineered skin. Tissue Eng 10 (2004) 1006-1017
31. Yao L., Swartz D.D., Gugino S.F., Russell J.A., and Andreadis S.T. Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity. Tissue Eng 11 (2005) 991-1003
32. Geer D.J., Swartz D.D., and Andreadis S.T. Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. Am J Pathol 167 (2005) 1575-1586
33. Koria P., and Andreadis S.T. Epidermal morphogenesis: the transcriptional program of human keratinocytes during stratification. J Invest Dermatol 126 (2006) 1834-1841
34. Singh R., and Andreadis S.T. EGFR activation decreases retroviral gene transfer through protein kinase C-delta. Mol Ther 15:15 2 (2006) 369-377
35. Neidert M.R., Lee E.S., Oegema T.R., and Tranquillo R.T. Enhanced fibrin remodeling in vitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents. Biomaterials 23 (2002) 3717-3731
36. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
37. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
38. Kaushal S., Amiel G.E., Guleserian K.J., Shapira O.M., Perry T., Sutherland F.W., et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7 (2001) 1035-1040
39. Saiura A., Sata M., Hirata Y., Nagai R., and Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 7 (2001) 382-383
40. Caplice N.M., Bunch T.J., Stalboerger P.G., Wang S., Simper D., Miller D.V., et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A 100 (2003) 4754-4759 [Electronic publication 2003 Mar 28]
41. Simper D., Stalboerger P.G., Panetta C.J., Wang S., and Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 106 (2002) 1199-11204
42. Le Ricousse-Roussanne S., Barateau V., Contreres J.O., Boval B., Kraus-Berthier L., and Tobelem G. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature. Cardiovasc Res 62 (2004) 176-184
43. Cho S.W., Lim S.H., Kim I.K., Hong Y.S., Kim S.S., Yoo K.J., et al. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 241 (2005) 506-515
44. Kashiwakura Y., Katoh Y., Tamayose K., Konishi H., Takaya N., Yuhara S., et al. Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow. Circulation 107 (2003) 2078-2081
45. Solan A., and Niklason L. Age effects on vascular smooth muscle: an engineered tissue approach. Cell Transplant 14 (2005) 481-488
46. Gong Z., and Niklason L.E. Blood vessels engineered from human cells. Trends Cardiovasc Med 16 (2006) 153-156
47. Andreadis S.T. Experimental models and high-throughput diagnostics for tissue regeneration. Expert Opin Biol Ther 6 (2006) 1071-1086
48. Owens G.K., Kumar M.S., and Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84 (2004) 767-801